Your browser doesn't support javascript.
loading
Risk factors of tumor lysis syndrome in relapsed/refractory multiple myeloma patients undergoing BCMA CAR-T cell therapy.
Zhang, Qiqi; Zu, Cheng; Meng, Ye; Lyu, Yuqi; Hu, Yongxian; Huang, He.
  • Zhang Q; 1. Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Zu C; 2. Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China.
  • Meng Y; 3. Institute of Hematology, Zhejiang University, Hangzhou 310058, China.
  • Lyu Y; 4. Zhejiang Provincial Laboratory for Stem Cell and Immunity Therapy, Hangzhou 310058, China.
  • Hu Y; 1. Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Huang H; 2. Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 51(2): 144-150, 2022 Apr 25.
Article en En | MEDLINE | ID: mdl-36161293
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Lisis Tumoral / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Lisis Tumoral / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article